Immuno-Oncology360º Announces 2024 Keynotes and Featured Speakers for the 10th Annual NYC Meeting
Retrieved on:
Thursday, October 19, 2023
Data mining, Margaret Callahan, IPO, EVP, UCSF, Optimism, Memorial Sloan Kettering Cancer Center, III, RNA, Life, University of California, Conference, PD-1, Doctor of Philosophy, MBA, Citigroup, R, Fidelity Investments, Cancer immunology, University, Pittsburgh, NYU Langone Health, Genentech, Ira Mellman, AI, FACP, Diagnosis, Research fellow, Weill Cornell Medicine, H. Lee Moffitt Cancer Center & Research Institute, Video game, Management, Medical device, Pharmaceutical industry, MD, Immunotherapy, IO
NEW YORK, Oct. 19, 2023 /PRNewswire-PRWeb/ -- The Conference Forum today announced the launch of the 10th annual Immuno-Oncology 360º Summit (IO360°) taking place February 27-29, 2024, at New York Marriott Brooklyn Bridge, in Brooklyn, NY.
Key Points:
- The Conference Forum announced the IO360º Summit's 2024 keynotes and featured speakers for its 10th annual conference.
- NEW YORK, Oct. 19, 2023 /PRNewswire-PRWeb/ -- The Conference Forum today announced the launch of the 10th annual Immuno-Oncology 360º Summit (IO360°) taking place February 27-29, 2024, at New York Marriott Brooklyn Bridge, in Brooklyn, NY.
- The IO360° 2024 keynotes include:
Genentech's Ira Mellman, PhD, VP, Cancer Immunology, will speak on the roles of data mining and AI, and other clinical and translational data, in discovery and trial design. - "The IO360º conference presents the latest data impacting the IO landscape and for the 10th annual event, we are pleased to announce the extraordinary leadership advancing this space.